Stem Cell Transplant and Cellular Therapies Symposium: Improving Access and Equity to Evolving Therapies
Please Note: This is a virtual event via Accelevents
https://www.accelevents.com/e/dfcisymposium2021
Description
Join clinical leaders from Dana-Farber Cancer Institute, Brigham and Women’s Hospital, and Boston Children’s Hospital in the Transplant & Cell Therapies Annual Symposium: Improving Access and Equity to Evolving Therapies
Target Audience
This activity is intended for local referring providers, nurses, PAs, pharmacists, payer representatives, case managers.
Learning Objectives
Upon completion of this activity, participants will be able to:
- Demonstrate comprehension of the referral process and care coordination between the community oncologist and the transplant team, including the pre-transplant workup process.
- Identify common and uncommon post-treatment toxicities post-treatment and differentiate between various common, chronic, and advanced infections post-treatment.
- Demonstrate comprehension of the use of haploidentical transplantation and its practicality.
- Review other non-infectious concerns that may present during short-term and long-term recovery from treatment.
- Categorize common toxicities during CAR T-cell treatment 6. Discuss latest therapies in research and clinical practice
Additional Information
Dana-Farber Cancer Institute and Mass General Brigham
Corey Cutler, MD, MPH, FRCPC - Course Director
Medical Director, Division of Transplant and Cell Therapies,
Dana-Farber Cancer Institute
Abigail Ciampa, NP
Nurse Practitioner, Adult Survivorship Clinic,
Dana-Farber Cancer Institute
Joseph H. Antin, MD
Jock and Bunny Adams Chair in Hematology,
Professor of Medicine, Harvard Medical School;
Dana-Farber Cancer Institute
Clifton Mo, MD
Clinical Director, Multiple Myeloma Division,
Dana-Farber Cancer Institute
Caron Jacobson, MD
Medical Director, Immune Effector Cell Therapy Program,
Dana-Farber Cancer Institute
Rizwan Romee, MD
Director, Haploidentical Transplantation Program,
Dana-Farber Cancer Institute
Dana Yoo, PhD
Director of Innovation,
National Marrow Donor Program/ Be The Match
Desiree Otenti, NP
Sr. Director of Medical Policy,
Blue Cross Blue Shield MA
Ludmila Svoboda, RN, BSN, MA, OCN
Program Nurse, Cancer Care Equity Program,
Dana-Farber Cancer Institute
Leslie Lehmann, MD
Associate Program Director, Fellowship and Training and Quality ,
Pediatric Hematopoietic Stem Cell Transplant Program,
Dana-Farber Cancer Institute/Boston Children’s Hospital
Sarah Hammond, MD
Director, Hematology/Oncology Infectious Disease,
Massachusetts General Hospital
Kecia Boyd, DNP, RN, NEA-BC, AOCNS, BMTCN
Director, Nursing and Patient Care Services Inclusion, Diversity, and Equity,
Dana-Farber Cancer Institute
Amy Emmert
Executive Director for External Affairs, Division of Transplant and Cell Therapies Service Line,
Dana-Farber Cancer Institute
Kidest Mequanent
Senior Program Manager, Cell Therapies and Shared Care,
Dana-Farber Cancer Institute
Julie Porter
Vice President of Cellular Therapy Operations,
Dana-Farber Cancer Institute
Mass General Brigham is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Mass General Brigham designates this live activity for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing
Credit Designation Statement
3.83 Contact Hour(s) of Nursing Continuing Professional Development (NCPD), will be awarded for attending the presentation in its entirety and completing an evaluation.
Approval Statement
Dana-Farber Cancer Institute is approved as a provider of nursing continuing professional development by the American Nurses Association Massachusetts, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
Available Credit
- 4.00 AMA PRA Category 1 Credit™
- 3.83 Nursing Contact Hours
- 4.00 Participation
Price
If you are having difficulty registering for the event, please reach out to the Mass General Brigham Office of Continuing Professional Development at partnerscpd@partners.org
Cancellation Policy:
Registrations cancelled on or before September 17, 2021 will be refunded, less a $15 administrative fee. Registrations cancelled after September 17, 2021 will not be refunded.
Contact partnerscpd@partners.org if you require assistance in cancelling your online registration.